Skip to the page

Data / Form D filings / SMSbiotech, Inc.

SMSbiotech, Inc.: Form D filing

SMSbiotech, Inc., a biotechnology company in San Marcos, CA, filed a Form D with the SEC in 2025. The latest, on October 15, 2025, reports an offering of $15.8 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1825 DIAMOND STREET, SUITE 101, San Marcos, CA, 92078
Phone
(760) 290-3406
Industry
Biotechnology
Entity type
Corporation
Incorporated in
California
Revenue range
No Revenues
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
2075778

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 15, 2025New notice$15,752,800$0$15,752,8000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Harry FriedmanExecutive Officer, Director
Joseph KianiDirector
Ghassan KassabDirector
Mohamed DiabDirector
Abdulkader Rahmo, Ph.D.Executive Officer, Director, Promoter

Other biotechnology companies in California that filed recently

Every Form D from the week of Oct 13, 2025 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what SMSbiotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.